LCM-29512-61545
3 vaccinations
3 coded responses
15 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 913 / CA
- Registered
- 2021-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-22
Dose 1 — Pfizer-BioNTech
-
2021-05-13
Dose 2 — Pfizer-BioNTech
-
2021-12-21
Dose 3 — Pfizer-BioNTech
-
2021-12-22
Registered in v-safe
-
2021-12-22
Survey response — days 1–6 daily, dose 3MedDRA: Tinnitus — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: TinnitusMedDRA releases: 2024-11 · check-in free text available
- 2021-12-23
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitAdult check-in
-
2021-12-24
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2021-12-27
- 2021-12-28
- 2022-01-04
- 2022-01-11
-
2022-01-18
Survey response — day 28, dose 3MedDRA: Chills, Dizziness, Nausea, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fever, chills, nausea, dizzinessMedDRA releases: 2024-11 · check-in free text available
- 2022-01-25
- 2022-02-01
- 2022-03-22
-
2022-06-21
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: Covid-19MedDRA releases: 2024-11 · check-in free text available
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-22 | Pfizer-BioNTech | No |
| 2 | 2021-05-13 | Pfizer-BioNTech | No |
| 3 | 2021-12-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Tinnitus
Release 10 — day 28, dose 3
Symptoms: Fever, chills, nausea, dizziness
Release 12 — 6 months, dose 3
Symptoms: Covid-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Tinnitus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release